ClinVar Miner

Submissions for variant NM_006269.2(RP1):c.1118C>T (p.Thr373Ile)

gnomAD frequency: 0.00985  dbSNP: rs77775126
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000178267 SCV000230314 benign not specified 2014-06-12 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000270795 SCV000474169 benign Retinitis pigmentosa 2018-03-06 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
GeneDx RCV001426942 SCV000521099 benign not provided 2019-11-13 criteria provided, single submitter clinical testing Reported in the heterozygous state in an individual with autosomal dominant retinitis pigmentosa (adRP); however, this variant failed to co-segregate with the disease in other affected family members. In addition, this variant was observed in 2/95 control individuals, leading the authors to suggest this is a benign variant (Berson et al., 2001); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 15863674, 11527933, 21147909, 25097241, 11095597, 24705292, 24123366, 25333069, 27884173, 27535533)
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000006334 SCV001157264 benign Retinitis pigmentosa 1 2023-06-28 criteria provided, single submitter clinical testing
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV000006334 SCV001435284 likely benign Retinitis pigmentosa 1 criteria provided, single submitter research The homozygous p.Thr373Ile variant in RP1 has been identified in at least 2 individuals with autosomal recessive retinitis pigmentosa (PMID: 15863674), but has also been identified in >2% of South Asian chromosomes and 23 homozygotes by ExAC (http://gnomad.broadinstitute.org/). In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely benign for autosomal recessive retinitis pigmentosa.
Labcorp Genetics (formerly Invitae), Labcorp RCV001426942 SCV001629608 likely benign not provided 2024-01-31 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000006334 SCV002796281 likely benign Retinitis pigmentosa 1 2022-02-06 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001426942 SCV004155809 benign not provided 2024-07-01 criteria provided, single submitter clinical testing RP1: BP4, BS1, BS2
Breakthrough Genomics, Breakthrough Genomics RCV001426942 SCV005223582 likely benign not provided criteria provided, single submitter not provided
OMIM RCV000006334 SCV000026516 pathogenic Retinitis pigmentosa 1 2005-05-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.